ClinConnect ClinConnect Logo
Search / Trial NCT05046392

mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV

Launched by RHODE ISLAND HOSPITAL · Sep 15, 2021

Trial Information

Current as of November 13, 2025

Recruiting

Keywords

Hiv Medication Adherence M Health Health Coaching

ClinConnect Summary

This clinical trial is studying a new way to help people living with HIV take their medications as prescribed. Researchers know that when patients stick to their HIV treatments, they can live longer and healthier lives. However, many patients struggle with medication adherence, which means they don’t always take their medications on time or as directed. In this study, 400 participants will be recruited from Providence, RI, and Atlanta, GA, and will be randomly assigned to either receive health coaching along with a smartphone app that sends reminders and allows them to communicate with their coach, or just the health coaching without the app.

To be eligible for the trial, participants need to be at least 18 years old, diagnosed with HIV, and currently prescribed HIV medication that they have not been taking regularly. They also need to have a detectable level of the virus in their blood. Participants will share their experiences through interviews at several points during the study, including when they first join and at 1, 3, 6, and 12 months later. Some may be asked to participate in additional interviews after 18 and 24 months. This trial aims to see if using the app alongside health coaching can improve how well participants stick to their medication routine compared to standard care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • at least 18 years of age
  • prescribed ART
  • diagnosed with HIV
  • detectable viral load (\>20 copies/mL) in past 6 months
  • less than 100% self-reported medication adherence
  • Exclusion Criteria:
  • physical impairments that would prevent completion of the intervention
  • cognitive impairments that jeopardize informed consent and/or intervention comprehension
  • active psychosis
  • not fluent in English

About Rhode Island Hospital

Rhode Island Hospital, a leading academic medical center and a key component of the Lifespan health system, is committed to advancing medical research and improving patient care through innovative clinical trials. As a principal teaching hospital for The Warren Alpert Medical School of Brown University, it integrates cutting-edge research with high-quality clinical services. The hospital's extensive clinical trial program spans various fields, including oncology, cardiology, neurology, and more, aiming to enhance treatment options and patient outcomes. By fostering collaboration among researchers, clinicians, and patients, Rhode Island Hospital plays a pivotal role in translating scientific discoveries into effective therapies and improving healthcare delivery.

Locations

Providence, Rhode Island, United States

Atlanta, Georgia, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials